Covington Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $119K | Sell |
412
-75
| -15% | -$21.7K | 0.01% | 433 |
|
|
2022
Q2 | $137K | Sell |
487
-38
| -7% | -$10.7K | 0.01% | 414 |
|
|
2022
Q1 | $137K | Buy |
525
+181
| +53% | +$47.2K | ﹤0.01% | 430 |
|
|
2021
Q4 | $76K | Sell |
344
-55
| -14% | -$12.2K | ﹤0.01% | 486 |
|
|
2021
Q3 | $72K | Buy |
399
+30
| +8% | +$5.41K | ﹤0.01% | 495 |
|
|
2021
Q2 | $74K | Buy |
369
+269
| +269% | +$53.9K | ﹤0.01% | 485 |
|
|
2021
Q1 | $21K | Buy |
100
+25
| +33% | +$5.25K | ﹤0.01% | 600 |
|
|
2020
Q4 | $18K | Hold |
75
| – | – | ﹤0.01% | 598 |
|
|
2020
Q3 | $20K | Hold |
75
| – | – | ﹤0.01% | 552 |
|
|
2020
Q2 | $22K | Hold |
75
| – | – | ﹤0.01% | 544 |
|
|
2020
Q1 | $18K | Sell |
75
-34
| -31% | -$8.16K | ﹤0.01% | 543 |
|
|
2019
Q4 | $24K | Buy |
109
+34
| +45% | +$7.49K | ﹤0.01% | 574 |
|
|
2019
Q3 | $13K | Sell |
75
-20
| -21% | -$3.47K | ﹤0.01% | 622 |
|
|
2019
Q2 | $17K | Hold |
95
| – | – | ﹤0.01% | 577 |
|
|
2019
Q1 | $17K | Buy |
95
+20
| +27% | +$3.58K | ﹤0.01% | 557 |
|
|
2018
Q4 | $12K | Hold |
75
| – | – | ﹤0.01% | 609 |
|
|
2018
Q3 | $14K | Sell |
75
-116
| -61% | -$21.7K | ﹤0.01% | 574 |
|
|
2018
Q2 | $32K | Hold |
191
| – | – | ﹤0.01% | 483 |
|
|
2018
Q1 | $31K | Hold |
191
| – | – | ﹤0.01% | 483 |
|
|
2017
Q4 | $29K | Buy |
191
+116
| +155% | +$17.6K | ﹤0.01% | 526 |
|
|
2017
Q3 | $11K | Buy |
+75
| New | +$11K | ﹤0.01% | 606 |
|